DMXL2 is a transmembrane protein that is overexpressed in resistant breast cancer cell lines, is an activator of the epithelial-to-mesenchymal transition, and is a potential new biomarker for hormone-positive breast cancer (Valter et al., 2023; Faronato et al., 2015). The gene discussed is DMXL2; the disease is breast cancer.